COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study

    March 2024 in “ PubMed
    Katerina Damevska, Tomica Sotirovski, Bojana Batkoska, Marija Djambazova, Vaska Radeski, Jorde Simonoska, Dimitri Bachevski, Kujtime Rushiti Mehmeti, Tomche Popovski, Ermira Labenishta, Aleksandar Ristovski, Anita Najdova
    Image of study
    TLDR Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
    This prospective cohort study assessed the prevalence of telogen effluvium (TE) in 77 patients hospitalized for severe COVID-19. Results showed that 68.8% of patients experienced TE, with 52.8% reporting early onset and 50.9% reporting moderate hair loss. Complete hair regrowth occurred in 20.7% of patients within three months and in 60.3% within six months, while 7.5% had chronic TE. Female sex, anemia, hypoproteinemia, and severe pneumonia were significantly associated with TE. The study highlights a high prevalence of COVID-19-associated TE, which generally has a good prognosis but can lead to chronic TE in a minority of cases.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 417 results

    Similar Research

    5 / 1000+ results